Published by Michele Maatouk on 3rd May 2023
(Sharecast News) - RBC Capital Markets lifted its price target on Hikma Pharmaceuticals on Wednesday to 2,050p from 1,950p as it reiterated its 'outperform' rating.
URL: http://www.digitallook.com/dl/news/story/33477805/...